Androgen resistance syndrome: genes and variants
Explore variant evidence for Androgen resistance syndrome across 1 analyzed protein (AR). Linked ClinVar records include 85 pathogenic or likely pathogenic variants, 58 variants of uncertain significance and 22 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Androgen resistance syndrome
AR: Androgen receptor
Androgen binding redirects its transcriptional program to control male sexual differentiation, reproductive physiology, muscle and bone biology, and other androgen-responsive processes. Loss-of-function variants cause androgen insensitivity, CAG expansion causes spinal and bulbar muscular atrophy, and persistent signaling drives prostate cancer.
85 ClinVar pathogenic / likely pathogenic and 80 uncertain variants in AR have source records linked to Androgen resistance syndrome. Association strength is not clinical gene validity.
Where Androgen resistance syndrome variants cluster
- AR Interaction with LPXN (positions 552–919): 82 of 84 ClinVar pathogenic / likely pathogenic variants, 2.4× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Androgen resistance syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| AR D696N | 696 | NR LBD | Pathogenic / likely pathogenic (★★★★) |
| AR R856H | 856 | NR LBD | Pathogenic / likely pathogenic (★★★★) |
| AR N757S | 757 | NR LBD | Pathogenic / likely pathogenic (★★★★) |
| AR R616C | 616 | Nuclear receptor | Pathogenic / likely pathogenic (★★) |
| AR R616H | 616 | Nuclear receptor | Pathogenic / likely pathogenic (★★) |
| AR R775H | 775 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR R775C | 775 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR R832Q | 832 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR R856C | 856 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR V904L | 904 | Interaction with KAT7 | Pathogenic / likely pathogenic (★★) |
| AR A588P | 588 | Nuclear receptor | Pathogenic / likely pathogenic (★★) |
| AR R608Q | 608 | Nuclear receptor | Pathogenic / likely pathogenic (★★) |
| AR A688V | 688 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR N706S | 706 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR R753Q | 753 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR A766T | 766 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR H777D | 777 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR M781I | 781 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR V890M | 890 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR V867M | 867 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR A871V | 871 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR A597T | 597 | Nuclear receptor | Pathogenic / likely pathogenic (★★) |
| AR D733N | 733 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR M750V | 750 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR Q825K | 825 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR P914S | 914 | Interaction with KAT7 | Pathogenic / likely pathogenic (★★) |
| AR M1L | 1 | Modulating | Pathogenic / likely pathogenic (★★) |
| AR S579T | 579 | Nuclear receptor | Pathogenic / likely pathogenic (★) |
| AR S579R | 579 | Nuclear receptor | Pathogenic / likely pathogenic (★) |
| AR E682G | 682 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR D691E | 691 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR D691G | 691 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR D696V | 696 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR G709E | 709 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR G709V | 709 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR R832G | 832 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR R856P | 856 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR P893R | 893 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR P893S | 893 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR V904M | 904 | Interaction with KAT7 | Pathogenic / likely pathogenic (★) |
| AR C577R | 577 | Nuclear receptor | Pathogenic / likely pathogenic (★) |
| AR K581T | 581 | Nuclear receptor | Pathogenic / likely pathogenic (★) |
| AR F583L | 583 | Nuclear receptor | Pathogenic / likely pathogenic (★) |
| AR R586K | 586 | Nuclear receptor | Pathogenic / likely pathogenic (★) |
| AR D605G | 605 | Nuclear receptor | Pathogenic / likely pathogenic (★) |
| AR K610E | 610 | Nuclear receptor | Pathogenic / likely pathogenic (★) |
| AR L617P | 617 | Nuclear receptor | Pathogenic / likely pathogenic (★) |
| AR N692K | 692 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR N693K | 693 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR S697Y | 697 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR L701F | 701 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR L723F | 723 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR F726L | 726 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR S741P | 741 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR E773G | 773 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR R780P | 780 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR L831F | 831 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR L839I | 839 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR L864R | 864 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR A871E | 871 | NR LBD | Pathogenic / likely pathogenic (★) |
Showing 60 of 85.
Which prediction tools work for Androgen resistance syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 98 out of 100
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 94 out of 100
- MetaLR: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 87 out of 100
- MetaSVM: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 83 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 76 out of 100
Same protein, different disease
- Differences in sex development also has ClinVar records linked to AR variants; they fall in the same places as the Androgen resistance syndrome variants (9 pathogenic / likely pathogenic).
- Male infertility also has ClinVar records linked to AR variants; they fall in the same places as the Androgen resistance syndrome variants (7 pathogenic / likely pathogenic).
- Partial androgen insensitivity syndrome also has ClinVar records linked to AR variants; they fall in the same places as the Androgen resistance syndrome variants (7 pathogenic / likely pathogenic).
- Ovarian cancer also has ClinVar records linked to AR variants; they fall mostly in different places as the Androgen resistance syndrome variants (4 pathogenic / likely pathogenic).
- Prostate cancer also has ClinVar records linked to AR variants; they fall mostly in different places as the Androgen resistance syndrome variants (3 pathogenic / likely pathogenic).
Diseases related to Androgen resistance syndrome
- Kennedy disease, also linked to AR
- Ovarian cancer, also linked to AR
- Differences in sex development, also linked to AR
- Male infertility with azoospermia or oligozoospermia due to single gene mutation, also linked to AR
- Male infertility, also linked to AR
- Partial androgen insensitivity syndrome, also linked to AR
- Disorder of sexual differentiation, also linked to AR
- Prostate cancer, also linked to AR
- Hypospadias, also linked to AR
Frequently asked questions
Which genes have records linked to Androgen resistance syndrome?
This view contains 1 analyzed proteins: AR. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 85 pathogenic or likely pathogenic variants, 58 variants of uncertain significance and 22 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 183 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center